<DOC>
	<DOCNO>NCT00828438</DOCNO>
	<brief_summary>The purpose study evaluate PK property lorcaserin subject end stage renal disease ( ESRD ) require dialysis study dialysis non-dialysis condition .</brief_summary>
	<brief_title>Pharmacokinetic Properties Lorcaserin Subjects With Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>1 . Males female age 18 79 year ( inclusive ) 2 . Able give sign informed consent 3 . Renal function fall one follow category ( ideal body weight use calculation ) : Onefifth subject normal renal function , define creatinine clearance &gt; 80 mL/min calculate use CockroftGault equation Onefifth subject creatinine clearance 5180 mL/min Onefifth subject creatinine clearance 3150 mL/min Onefifth subject creatinine clearance 530 mL/min , require dialysis Onefifth subject chronic end stage renal disease , require regularly schedule hemodialysis , stable hemodialysis regimen least 3 month prior dose 4 . Subjects renally impaired group stable renal disease per Investigator 's assessment , clinically meaningful change 1 month prior randomization . 5 . Subjects group BMI 2745 kg/m2 . 6 . Considered stable health opinion Investigator . 7 . Eligible male female subject must agree participate conception process . 1 . Prior participation study lorcaserin . 2 . Clinically significant new illness 1 month screen 3 . Not suitable participate study opinion Investigator include exist physical mental condition prevents compliance protocol 4 . History follow cardiovascular condition : Myocardial infarction ( diagnosed cardiac enzyme [ ] and/or diagnostic ECG ) , CVA , TIA RIND within 3 month screen Cardiac arrhythmia require initiation new medical surgical treatment within 3 month screen ( pacemaker and/or defibrillator implant &gt; 3 month prior screen acceptable ) Unstable angina History pulmonary artery hypertension 5 . Positive result HIV , hepatitis B hepatitis C screen . 6 . Malignancy within 2 year screen visit ( except basal cell squamous cell carcinoma clean surgical margin ) 7 . Use SSRI 's , SNRI 's , medication must meet washout period . 8 . Recent history ( within 3 month prior screen visit ) alcohol drug/solvent abuse positive screen drug abuse screen . 9 . Participated clinical study investigational drug , biologic , device within 1 month prior dose 10 . Unwilling , whose partner unwilling , use adequate mean contraception 1 month follow completion/withdrawal study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>